Market Newsdesk

Hapbee Completes CE Certification, Enabling Entry into European Market

(TSXV: HAPB)

VANCOUVER, BC, Dec 1, 2020 /PRNewswire/ – Hapbee Technologies, Inc. (TSXV: HAPB) (“Hapbee“ or the “Company“), a wellness technology company developing the revolutionary Hapbee wearable, is pleased to announce it is advancing several new signals into the closed beta phase of testing. Pending successful testing completion and licensing arrangements with EMulate Therapeutics, Inc., there will be a new signal launch through the Hapbee Companion App in Q1 2021.

“Our team has identified several promising signal candidates that have the potential to enhance moments in people’s daily lives,” said Scott Donnell, Chief Executive Officer of Hapbee. “Following successful completion of closed beta testing with humans and licensing activities, we aim to launch at least one of these new signals through the Hapbee Companion App in early 2021. The development of new signals is paramount to our organizational goal of continually providing Hapbee members with new experiences.”

The Company expects to begin closed beta testing of the signals in the coming weeks.

Completed CE Certification for Wearable Wellness Product

Hapbee has completed Conformitè Europëenne (“CE”) certification and declaration for its wearable wellness product, enabling it to be sold within the European Union (“EU”). The EU is home to over 500 million consumers across 28 member countries, making it the second largest consumer market in the world.

The CE mark signifies that a product sold in the European Economic Area has been assessed to meet high safety, health, and environmental protection requirements. CE marking does not indicate that a product has been approved as safe by the EU or by another authority.

About Hapbee

Hapbee is a wearable magnetic field technology company that aims to help people choose how they feel. Powered by patented ultra-low radio frequency energy (ulRFE^®) technology invented and licensed by EMulate Therapeutics, Inc., Hapbee delivers low-power electromagnetic signals designed to produce sensations such as Happy, Alert, Focus, Relax, Calm and Sleepy.

You can learn more about how Hapbee works at www.hapbee.com/science

Forward-Looking Information Disclaimer

Certain statements included in this news release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This news release contains forward looking statements. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors. Any statements about Hapbee’s business plans or its upcoming development targets – including development of the Hapbee smartphone app, manufacturing and shipping for the Indiegogo campaign, research and development of new signals and the Company’s pursuit of a public listing – are all forward-looking information. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including, anticipated costs, and the ability to achieve its goals.

Factors that could cause the actual results to differ materially from those in the forward-looking statements include, failure to obtain regulatory approval, the continued availability of capital and financing, and general economic, market or business conditions, changes in legislation and regulations, increase in operating costs, equipment failures, failure of counterparties to perform their contractual obligations, litigation, the loss of key directors, employees, advisors or consultants and fees charged by service providers. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. These risks, uncertainties and assumptions include, but are not limited to, those described in Hapbee prospectus dated October 26, 2020, a copy of which is available on SEDAR at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there be no assurance that the listing of the common shares of the Company will occur. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information, visit: www.hapbee.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hapbee-advances-new-signals-into-closed-beta-phase-301182606.html

SOURCE Hapbee Technologies Inc.

SAN JOSE, Calif., Dec. 1, 2020 /PRNewswire/ — Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that it has entered into a license agreement with Cleveland Clinic for exclusive, world-wide rights to an innovative ovarian cancer vaccine technology. 

Cleveland Clinic immunologist Dr. Vincent Tuohy has been working on a method to vaccinate women against ovarian cancer and other gynecological malignancies.  This development-stage vaccine targets the extracellular domain of anti-mullerian hormone receptor 2 (AMHR2-ED), that appears in many types of ovarian cancer.  AMHR2-ED is one of several proteins identified by Dr. Tuohy as “retired” proteins.  While these proteins are necessary during the early stages of life, they are “retired” as a person ages, and are no longer expressed, or made at appreciable levels, in healthy adults.  AMHR2-ED re-appears in cancerous cells and accordingly, it is an attractive target for vaccination.

Anixa and Cleveland Clinic are already collaborating on a preventative breast cancer vaccine also developed by Dr. Tuohy based on his research into “retired” proteins.  The organizations plan to begin human trials with the breast cancer vaccine in early 2021.

“Through this collaboration we are expanding into additional preventive and therapeutic areas and we look forward to seeing the development of this ovarian cancer vaccine,” said Dr. Tuohy. “Research into cancer therapies has typically focused on attacking the disease after a patient has been diagnosed, but if we could immunize people to prevent the cancer from ever forming, it could represent a paradigm shift for patients, their caregivers and the healthcare system.”

“We are pleased to broaden our relationship and to expand our work with Dr. Tuohy,” stated Amit Kumar, Ph.D., President and Chief Executive Officer of Anixa.  “Though it is still early days for the experimental ovarian cancer vaccine, pre-clinical research suggests the potential of this technology as both a prophylactic that prevents the occurrence of cancer, and a therapeutic that treats women with ovarian cancer.”

Dr. Kumar added, “Anixa’s goal is to present patients that have limited treatment options with meaningful new therapeutic and prophylactic alternatives.  We see this vaccine as a complementary component to our growing immuno-oncology portfolio, which includes a CAR-T therapy targeting ovarian cancer, for which we anticipate filing an IND shortly.”

Conference Call Information:
Anixa will host a conference call and live audio webcast Thursday, December 3, 2020, at 1:15 p.m. PST.  Interested parties may access the conference call by dialing:

• (877) 876-9176
• Conference ID: Anixa

An audio webcast will be accessible via the Investors section of the Anixa website:  https://ir.anixa.com/events.  An archive of the webcast will remain available for 30 days after the call.

About Anixa Biosciences, Inc.

Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.  Anixa’s therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function.  The company’s vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer.  These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer.  Anixa continually examines emerging technologies in complementary fields for further development and commercialization.  Additional information is available at www.anixa.com.

Forward-Looking Statements:
  Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are not statements of historical facts, but rather reflect Anixa’s current expectations concerning future events and results.  We generally use the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “will” and similar expressions to identify forward-looking statements.  Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements.  These risks, uncertainties and factors include, but are not limited to, those factors set forth in “Item 1A – Risk Factors” and other sections of our most recent Annual Report on Form 10-K as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.  We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.  You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release. 

Investor contact:
Mike Catelani
[email protected] 
408-708-9808

Media contact:
Sherry Ash
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/anixa-biosciences-announces-licensing-agreement-with-cleveland-clinic-for-ovarian-cancer-vaccine-technology-301182646.html

SOURCE Anixa Biosciences, Inc.

PHOENIX, Dec. 1, 2020 /PRNewswire/ — Honeywell (NYSE: HON) has unveiled a new catalyst designed for aircraft cabin air systems that can help reduce delays, cancellations and unscheduled maintenance due to in-cabin odors from certain volatile organic compounds in “bleed air” — also known as undesirable “smell-in-cabin” events. In clinical tests, Honeywell’s fourth-generation Combined Hydrocarbon Ozone Catalyst, CHOC4, has proved capable of removing two to three times more VOCs that cause undesired odors compared with other solutions. Honeywell’s solution has also been shown to be more effective in the removal of ozone at lower temperatures.

Air supplied to a cabin for air conditioning and pressurization, also known as bleed air, comes directly from the engines and auxiliary power unit. Sometimes it contains volatile organic compounds (VOCs), fumes or particles from sources like jet fuel, hydraulic oils or de-icing fluid. When VOCs enter the cabin through the bleed air, they can cause unwanted odors in the cabin, resulting in delays.

“Severe smell-in-cabin incidents can cost airlines up to $50 million per year in flight disruptions and unscheduled maintenance,” said Tom Hart, vice president and general manager, Air & Thermal Systems, Honeywell Aerospace. “CHOC4 reduces VOCs from the engines and bleed air supply, thereby reducing the severity and frequency of these incidents.”

Honeywell’s new proprietary catalyst CHOC4 is applied to an aircraft’s ozone converter to catalyze or absorb compounds that cause undesirable odors. It can be applied during normal maintenance as an upgrade to the existing converter unit at a fraction of the cost of a new unit. It is available now for Airbus A320 aircraft, with plans to expand to additional platforms in early 2021.

Thousands of passenger, cargo and military aircraft worldwide are currently flying with Honeywell environmental, air and thermal systems on board. Now, Honeywell is using its decades of experience developing cabin air-management systems to help improve in-flight comfort. 

To learn more about CHOC4, please visit aerospace.honeywell.com.

About Honeywell
Honeywell Aerospace products and services are found on virtually every commercial, defense and space aircraft. The Aerospace business unit builds aircraft engines, cockpit and cabin electronics, wireless connectivity systems, mechanical components and more. Its hardware and software solutions create more fuel-efficient aircraft, more direct and on-time flights and safer skies and airports. For more information, visit www.honeywell.com or follow us at @Honeywell_Aero.

Honeywell (www.honeywell.com) is a Fortune 100 technology company that delivers industry-specific solutions that include aerospace products and services; control technologies for buildings and industry; and performance materials globally. Our technologies help aircraft, buildings, manufacturing plants, supply chains, and workers become more connected to make our world smarter, safer, and more sustainable. For more news and information on Honeywell, please visit www.honeywell.com/newsroom.

Contacts:

Media

Amanda Jensen

+1 (602) 245-9033
[email protected] 

View original content to download multimedia:http://www.prnewswire.com/news-releases/honeywell-introduces-next-generation-catalyst-to-address-smell-in-cabin-events-301182631.html

SOURCE Honeywell

Wholesale Strategy Commences With Western Canada Channel Build Out

VANCOUVER, BC, Dec. 1, 2020 /PRNewswire/ – RYU Apparel Inc. (TSXV: RYU) (OTCQB: RYPPF) (FWB: RYAA) (“RYU” or the “Company“), a creator of award-winning urban athletic apparel, is pleased to welcome Chris White as Sales Manager for the Western Canada region.

Chris White is a 20-year sales veteran of the action culture and lifestyle apparel industries, with a core focus on top tier global apparel brands. Throughout his professional, consumer-focused career, Mr. White has worked with companies including Fox Racing, Converse, DC Shoes, Dickies, Burton Snowboards, Skull Candy, and Vissla.

Through his agency, Heavy Weight Sales, Mr. White will operate as an independent sales agent, introducing and scaling RYU’s best-in-class apparel to sport stores, skateboard and lifestyle shops in the markets of Manitoba, Saskatchewan, Alberta and British Columbia. 

Mr. White will commence sales operations immediately.

Said Chris White, “I truly embrace the opportunity to contribute to the success of a Canadian brand with such a positive message, supported by exceptional product. Joining the team at RYU is a natural complement to my lifestyle and I am excited for what the future holds.”

“I welcome Chris to our team,” said RYU CEO Cesare Fazari. “His connection and commitment to action sports culture and premium quality apparel is a tremendous fit with RYU. We’re excited to officially move forward with our wholesale roll out in the great provinces of Western Canada.” 

About RYU Apparel

RYU Apparel (TSXV: RYU, PINK: RYPPF, FWB: RYAA), or Respect Your Universe, is an award winning urban athletic apparel and accessories brand engineered for the fitness, performance and lifestyle of the athletic man and woman. Designed without compromise for fit, comfort, and durability, RYU exists to facilitate optimal human performance. For more information, please visit the RYU website at: http://ryu.com 

Forward Looking Statements Disclaimer

Neither the TSX Venture Exchange Inc. nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange Inc.) accepts responsibility for the adequacy or accuracy of this press release.

This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of RYU, such as statements the renewal of the RYU brand, sales in Western Canada, store growth or revenue increases through Mr. Whites addition to the team
.
There are numerous risks and uncertainties that could cause actual results and RYU’s plans and objectives to differ materially from those expressed in the forward-looking information, including:
(i
) adverse market conditions, including conditions arising as a result of the COVID-19 pandemic or otherwise; (ii) an inability to renew the RYU brand, implement strategic objectives and regain profitability; (iii) failing to meet target revenue projections as anticipated; (iv) failing to enter into the anticipated consulting arrangement and (v) the inability to complete the planned re-opening of the its store or the piloting of the “RYU Studio” concept. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking statements are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, RYU does not intend to update these forward-looking statements. 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ryu-apparel-inc-announces-apparel-industry-veteran-chris-white-as-western-canada-sales-manager-301182576.html

SOURCE RYU Apparel Inc.

ROLLING MEADOWS, Ill., Dec. 1, 2020 /PRNewswire/ — Arthur J. Gallagher & Co. (NYSE: AJG) today announced the acquisition of Seattle-based North Star Insurance Services, LLC and Fairhaven, Mass.-based North Star Marine Insurance Services, LLC. Terms of the transaction were not disclosed.

Founded in 2001, North Star Insurance Services is a full-service marine insurance broker serving clients throughout the U.S. Their expertise spans nearly all facets of the marine industry, including hull, machinery, marine liabilities and cargo for commercial fishing, tugs and barges, shipyards and ocean-going cargo vessels. In 2014, North Star Marine Insurance Services was established in Fairhaven to address growing customer demand in that region. John Walsh, Ian Blackburn and their associates will continue operating from their current locations under the direction of Jim Buckley, head of Gallagher’s Northwest region retail property/casualty brokerage operations.

“North Star brings us a widely recognized and well-respected team of marine professionals with strong carrier relationships and a client roster that complements our existing marine business,” said J. Patrick Gallagher, Jr., Chairman, President and CEO. “I am delighted to welcome John, Ian and their associates to Gallagher’s growing global team.”

Arthur J. Gallagher & Co., a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. The company has operations in 49 countries and offers client-service capabilities in more than 150 countries around the world through a network of correspondent brokers and consultants.

View original content to download multimedia:http://www.prnewswire.com/news-releases/arthur-j-gallagher–co-acquires-north-star-insurance-services-llc-and-north-star-marine-insurance-services-llc-301182625.html

SOURCE Arthur J. Gallagher & Co.

LOS ANGELES, Dec. 1, 2020 /PRNewswire/ — The DoubleLine Opportunistic Credit Fund (the “Fund”), which is traded on the New York Stock Exchange under the symbol DBL, this week declared a distribution of $0.110 per share for the month of December 2020. The distribution is subject to the following ex-dividend, record and payment dates set by the Fund’s Board of Trustees.

Separately, the Fund declared a special year-end distribution of $0.387 per share.

This news release is not for tax reporting purposes. The release has been issued to announce the amount and timing of the distributions declared by the Board of Trustees. There is a possibility that distributions may include ordinary income, long-term capital gains or return of capital. The amount of distributable income and the tax characteristics of the distributions are determined at the end of the taxable year. In early 2021, the Fund will send shareholders a Form 1099-DIV specifying how the distributions paid by the Fund during the prior calendar year should be characterized for purposes of reporting the distributions on a shareholder’s tax return.

About DoubleLine
Opportunistic Credit Fund

The DoubleLine Opportunistic Credit Fund (the “Fund”) is a diversified, closed-end management investment company. The Fund’s investment objective is to seek high total investment return by providing a high level of current income and the potential for capital appreciation. There is no guarantee that the Fund will achieve its investment objective. Investing in the Fund involves the risk of principal loss.

About DoubleLine Capital LP

DoubleLine Capital is an investment adviser registered under the Investment Advisers Act of 1940. DoubleLine’s offices can be reached by telephone at (213) 633-8200 or by e-mail at [email protected]. Media can reach DoubleLine by e-mail at [email protected]. DoubleLine® is a registered trademark of DoubleLine Capital LP.

To read about the DoubleLine Opportunistic Credit Fund, please access the Annual Report at www.doublelinefunds.com or call 877-DLINE11 (877-354-6311) to receive a copy. Investors should consider the Fund’s investment objective, risks, charges and expenses carefully before investing. An investment in the Fund should not constitute a complete investment program.

This document is not an offer to sell securities or the solicitation of an offer to buy securities, nor shall there be any sale or offer of these securities, in any jurisdiction where such sale or offer is not permitted.

Fund investing involves risk. Principal loss is possible.

Shares of closed-end investment companies frequently trade at a discount to their net asset value, which may increase investors’ risk of loss. This risk may be greater for investors expecting to sell their shares in a relatively short period after the completion of the public offering. There are risks associated with investment in the fund.

Investments in debt securities typically decline in value when interest rates rise. This risk is usually greater for longer-term debt securities. Investments in asset-backed and mortgage-backed securities include additional risks that investors should be aware of including credit risk, prepayment risk, possible illiquidity and default, as well as increased susceptibility to adverse economic developments.
Past performance is no guarantee of future results. The fund may invest in foreign securities which involve greater volatility and political, economic and currency risks and differences in accounting methods. These risks are greater for investments in emerging markets. Investments in lower rated and non-rated securities present a great risk of loss to principal and interest than higher rated securities. Investment strategies may not achieve the desired results due to implementation lag, other timing factors, portfolio management decisions-making, economic or market conditions or other unanticipated factors. In addition, the Fund may invest in other asset classes and investments such as, among others, REITs, credit default swaps, short sales, derivatives and smaller companies which include additional risks.
The DoubleLine Opportunistic Credit Fund (the “Fund”) is a diversified, closed-end management investment company.

This material may include statements that constitute “forward-looking statements” under the U.S. securities laws. Forward-looking statements include, among other things, projections, estimates, and information about possible or future results related to the Fund, market or regulatory developments. The views expressed herein are not guarantees of future performance or economic results and involve certain risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially from the views expressed herein. The views expressed herein are subject to change at any time based upon economic, market, or other conditions and DoubleLine undertakes no obligation to update the views expressed herein. While we have gathered this information from sources believed to be reliable, DoubleLine cannot guarantee the accuracy of the information provided. Any discussions of specific securities should not be considered a recommendation to buy or sell those securities. The views expressed herein (including any forward-looking statement) may not be relied upon as investment advice or as an indication of the Fund’s trading intent. Information included herein is not an indication of the Fund’s future portfolio composition.

Distributions include all distribution payments regardless of source and may include net income, capital gains, and/or return of capital (ROC). ROC should not be confused with yield or income. A Fund’s Section 19a-1 Notice, if applicable, contains additional distribution composition information and may be obtained by visiting www.doublelinefunds.com. Final determination of a distribution’s tax character will be made on Form 1099 DIV and sent to shareholders. On a tax basis, as of April 30, 2020, the most recent available figure, the estimated component of the cumulative distribution for the fiscal year to date would include an estimated return of capital of $0.000 (0%) per share. This amount is an estimate and the actual amounts and sources for tax reporting purposes may change upon final determination of tax characteristics and may be subject to changes based on tax regulations.

Any tax or legal information provided is merely a summary of our understanding and interpretation of some of the current income tax regulations and is not exhaustive. Investors must consult their tax advisor or legal counsel for advice and information concerning their particular situation. Neither the Fund nor any of its representatives may give legal or tax advice.

Quasar Distributors, LLC provides filing administration for DoubleLine Capital LP.

©2020 DoubleLine Capital LP.

View original content to download multimedia:http://www.prnewswire.com/news-releases/doubleline-opportunistic-credit-fund-declares-december-2020-distribution-and-special-dividend-301182627.html

SOURCE DoubleLine

KATY, Texas, Dec. 1, 2020 /PRNewswire/ — U.S. Silica Holdings, Inc. (NYSE: SLCA) said today that its Industrial and Specialty Products business will increase prices for most of its non-contracted silica sand, diatomaceous earth, perlite, cellulose and clay products used primarily in filtration, glass, foundry, paints, coatings, elastomers, roofing, chemicals, recreation, building products, agricultural, pet litter and other applications.

Price increases will range up to 15 percent, depending on the product and grade. The price increases are effective for shipments starting Jan. 1, 2021. 

The price increases will support the continued investments the Company is making in upgrading its capacity to meet the growing demand for its products and to offset rising production costs.

About U.S. Silica

U.S. Silica Holdings, Inc. is a global performance materials company and last-mile logistics provider and is a member of the Russell 2000 Index. The Company is a leading producer of commercial silica used in a wide range of industrial applications and in the oil and gas industry. Over its 120-year history, U.S. Silica has developed core competencies in mining, processing, logistics and materials science that enable it to produce and cost-effectively deliver over 400 diversified product types to customers across its multiple end markets. U.S. Silica’s wholly owned subsidiaries include EP Minerals and SandBox Logistics™. EP Minerals is an industry leader in the production of products derived from diatomaceous earth, perlite, engineered clays, and non-activated clays. SandBox Logistics™ is a state-of-the-art leader in proppant storage, handling and well-site delivery, dedicated to making proppant logistics cleaner, safer and more efficient. The Company currently operates 23 mines and production facilities. The Company is headquartered in Katy, Texas and has offices in Reno, Nevada and Chicago, Illinois.

U.S. Silica Holdings, Inc.

Arjun Sreekumar

Manager, Treasury and Investor Relations
281-394-9584
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/us-silica-announces-price-increases-on-industrial-and-specialty-products-301182622.html

SOURCE U.S. Silica Holdings, Inc.

CLAYMONT, Del., Dec. 1, 2020 /PRNewswire/ — Medicevo Corporation, a subsidiary of Corporate Universe, Inc. (OTC PINK:COUV), announced the launch and availability of its Graphene Face Mask, which is proven to filter 98% of COVID-19 particles, setting a new safety standard of Personal Protection Equipment (PPE) now available on the market. Medicevo’s Graphene Face Mask has been rigorously evaluated using the American Society for Testing and Materials (ASTM) standards for Medical Face Masks. The same tests that PPE used in hospitals, and by first responders must pass for use in high-risk situations.

Medicevo’s Graphene Face Mask uses a patented production process that implants graphene into the fabric of the mask directly, creating a microscopic sharp-edged netting. When a virus comes in contact with Medicevo’s Graphene Face Mask, the graphene netting slices through the virus particle, killing it. The masks are scientifically proven to kill COVID-19 particles and other types of infectious diseases like the seasonal flu, which is key for disease control and prevention.

In order to be approved by the U.S. Food and Drug Administration for use in hospitals, PPE must pass tests for flammability, differential pressure, particle filtration efficiency and bacterial filtration efficiency (BFE), and fluid resistance. Medicevo’s Graphene Face Mask has passed flammability testing and has scored a 4.2 out of 5 for differential breathability pressure. In addition, the masks scored a 98% BFE and a 96% particle filtration efficiency. The Masks have passed level two for fluid resistance.

“Our collective understanding of COVID-19 has greatly expanded since the start of the pandemic, as well as how to protect ourselves,” said Isaac Sutton, president, Medicevo Corporation. “Medicevo has taken the most advanced graphene technology and perfected the process of infusing it into our face mask’s fabric to create a PPE that is safer than the N95 respirator, which was widely considered the gold standard of safety until this point.”

Medicevo’s Graphene Face Mask features four layers of protection. The outer layer comprises high-quality antibacterial, non-woven fabric with strong air permeability but isolates droplets and large particles. The graphene layer and patented plating technology kill more than 99% of viruses and germs. A melt-blown cloth layer creates an isolation and dustproof effect, filtering particles less than 0.3 microns in size. Finally, a skin-friendly inner lining with honeycomb-woven fabric and adjustable ear loops stretch over the wearer’s nose and mouth to ensure a secure and airtight fit.

Medicevo is the exclusive distributor of the state-of-the-art Medicevo Graphene Face Mask in the United States and Canada. The mask is available to buy now and comes in sizes for children and adults. One package of five disposable face masks retails for $39.95. Each mask is reusable for up to 15 days.

For more information, or to purchase Medicevo’s Graphene Face Mask, visit https://Medicevo.com.

About Medicevo Corporation
Founded in 2020 amid the COVID-19 pandemic, Medicevo Corporation works to ensure the safety of healthcare professionals, frontline workers, and communities around the world by creating rapidly available and sustainable medical supplies. Made using a patented production process, Medicevo’s Graphene Face Mask is scientifically proven to kill COVID-19 particles and other types of germs and infectious diseases. Built with four layers of protection for the wearer, Medicevo’s Graphene Face Mask has been evaluated by the American Society for Testing and Materials standard. Medicevo’s Graphene Face Mask provides a Bacterial Filtration Efficiency (BFE) of 98% higher than N95 Masks or other face masks on the market. Medicevo Corporation is a subsidiary of Corporate Universe, Inc. (OTC PINK:COUV). For more information, visit https://Medicevo.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/medicevo-unveils-graphene-face-mask-which-filters-98-of-covid-19-particles-301182637.html

SOURCE Medicevo Corporation

MINNEAPOLIS, Dec. 1, 2020 /PRNewswire/ — Castlelake, L.P. (“Castlelake”), a global private investment firm with 15 years of tenure financing and managing aviation assets, together with Boeing (NYSE: BA)  and its subsidiary Boeing Capital Corporation, today announced a partnership to provide delivery financing solutions to commercial aircraft customers for new commercial aircraft deliveries.

Through the partnership, Castlelake will seek to provide up to $5 billion of capital for new Boeing commercial aircraft deliveries via senior secured financing, mezzanine financing and high loan-to-value finance leases. Castlelake will have full discretion over which transactions to pursue and the terms of those transactions. The term of the partnership is through December 31, 2022, and can be extended for an additional two years.

“We are excited to work with Boeing to provide efficient, tailored financing solutions to their customers while also providing us with an excellent investment opportunity,” said Evan Carruthers, Chief Investment Officer and Co-Founder of Castlelake. “We believe aviation will continue to be vital to our global economy and we look forward to expanding our longstanding relationship with Boeing and its customers to navigate the current environment.”  

“Boeing Capital’s strategy has always been and remains to ensure that a range of efficient financing solutions are available for customers who purchase our products,” said Tim Myers, President of Boeing Capital Corporation.  “We have known and worked with the team members at Castlelake for 15 years and are pleased to be able to partner with them on this important program. As the entire industry navigates through the global pandemic, partnerships like these are important steps to supporting stability and positioning for the opportunities ahead.”

The financing partnership comes as Castlelake expands its aviation investment strategy further into aviation lending. Having invested throughout various aviation business cycles since 2005 and with an aviation team of more than 60 dedicated professionals across underwriting, finance, technical and other specialized disciplines, Castlelake believes it can provide attractive, tailored capital solutions to aviation industry participants, including airlines and other aircraft buyers. Castlelake’s aviation lending strategy is led by Armin Rothauser, who joined the firm in November with more than 20 years of experience in credit, lending and hard assets.

About Castlelake
Castlelake, L.P. is a global private investment firm focused on investments in alternative assets, sub-performing notes and special situations, and is an experienced leader in aircraft ownership and servicing. With offices in Minneapolis, Dallas, New York, London, Dublin, Luxembourg and Singapore, the Castlelake team comprises more than 200 experienced professionals. As of September 30, 2020, Castlelake manages approximately $18.4 billion in assets, on behalf of its investors. For more information, please visit www.castlelake.com.

About Boeing
Boeing is the world’s largest aerospace company and leading provider of commercial airplanes, defense, space and security systems, and global services. As a top U.S. exporter, the company supports commercial and government customers in more than 150 countries. Boeing Capital Corporation is a global provider of financing solutions. A wholly-owned subsidiary of The Boeing Company, Boeing Capital offers asset-backed lending and leasing, concentrating on assets that are critical to the core operations of Boeing customers. Boeing Capital’s primary mission is to support the other Boeing business units by ensuring customers have the financing they need to buy and take delivery of their Boeing products.

Contact

Castlelake Media Relations

Molly Blemker

+1 612 851 3083
[email protected]                   

Prosek Partners

David Wells / Josh Clarkson / Mariel Seidman-Gati
[email protected] / [email protected] / [email protected]
+1 212 279 3115

Boeing

Peter Pedraza

+1 312 618 8998
[email protected] 

View original content:http://www.prnewswire.com/news-releases/castlelake-and-boeing-announce-aircraft-financing-collaboration-301182632.html

SOURCE Castlelake

CHAPEL HILL, N.C. and LANHAM, Md., Dec. 1, 2020 /PRNewswire/ — The University of North Carolina at Chapel Hill is launching an expansion of its digital learning platform, increasing online program offerings from across the University, including graduate degree, certificate, and professional development programs. The goal: to help thousands of people across the state, and many others around the nation and world, gain access to a world-class Carolina education and become lifelong learners. 

To support this expansion, 2U, Inc. (Nasdaq: TWOU), a global leader in education technology, will provide online program management for the University. Carolina is poised to launch an expanded portfolio of online graduate degree programs supported by 2U’s traditional full-investment model, as well as non-degree professional development programs. For smaller programs, the University will be able to access flexible services across 2U’s industry-leading capabilities. 2U already has successful, long-term relationships with Carolina’s Kenan-Flagler Business School, the Gillings School of Global Public Health, the UNC School of Government, and The William and Ida Friday Center for Continuing Education. 

Along with support from Carolina’s Digital and Lifelong Learning, faculty will lead the development of these programs with 2U, with initial degrees launching over the course of the next few years. The University will retain complete control over the core academic and governance functions (including admissions) in its online degree programs, as it does in its traditional campus-based programs. Carolina will work with 2U to design and build its new online model, enhance the institution’s internal capacity to create digital education programs, and advance digital education research more broadly through the creation of the University’s Digital Education Research Hub. 

“Carolina has a long history of working with 2U to create best-in-class graduate degree and boot camp programs,” UNC Chapel Hill Executive Vice Chancellor and Provost Bob Blouin said. “This University-wide partnership will accelerate our ambitious digital learning strategy, enabling us to leverage 2U’s expertise in developing and delivering world-class education programs online.”

“UNC Chapel Hill recognizes that digital learning is critical to the future of higher education. This first-of-its-kind partnership will give UNC Chapel Hill incredible flexibility to leverage the full spectrum of 2U’s technology, services, and expertise to bring its campus-wide digital strategy to life,” 2U President of Global Partnerships Andrew Hermalyn said.

This commitment to digital, flexible, and lifelong learning is a critical piece of the University’s educational mission and is a key component of Carolina Next: Innovations for Public Good, the University’s strategic plan, which aims to eliminate all barriers to a great education and meet the imperative for learning that is personalized, experiential, collaborative, and data-literate.

About the University of North Carolina at Chapel Hill: The University of North Carolina at Chapel Hill, the nation’s first public university, is a global higher education leader known for innovative teaching, research and public service. A member of the prestigious Association of American Universities, Carolina regularly ranks as the best value for academic quality in U.S. public higher education. Now in its third century, the University offers 77 bachelor’s, 107 master’s, 65 doctorate and seven professional degree programs through 14 schools, including the College of Arts & Sciences. Every day, faculty, staff and students shape their teaching, research and public service to meet North Carolina’s most pressing needs in every region and all 100 counties. Carolina’s 341,972 alumni live in all 50 states, the District of Columbia, U.S. Territories and 159 countries. More than 185,118 live in North Carolina.

About 2U, Inc. (Nasdaq: TWOU): Eliminating the back row in higher education is not just a metaphor—it’s our mission. For more than a decade, 2U, Inc., a global leader in education technology, has been a trusted partner and brand steward of great universities. We build, deliver, and support more than 475 digital and in-person educational offerings, including graduate degrees, professional certificates, Trilogy-powered boot camps, and GetSmarter short courses. Together with our partners, 2U has positively transformed the lives of more than 275,000 students and lifelong learners. To learn more, visit 2U.com. #NoBackRow

Media Contact:

Kate Welk

[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/unc-chapel-hill-launches-an-expansion-of-its-digital-and-lifelong-learning-platform-301182582.html

SOURCE 2U, Inc.